JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Antonello La Rocca
Michele Salati
Carmine La Manna
Francesco Scognamiglio
Gaetano Rocco
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Givigliano, F.
Right arrow Articles by Rocco, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Givigliano, F.
Right arrow Articles by Rocco, G.
Related Collections
Right arrow Lung - cancer
Right arrow Pleura

J Thorac Cardiovasc Surg 2008;135:704-705
© 2008 The American Association for Thoracic Surgery

Brief Communication

Visualization of bronchoalveolar fistula as the presenting sign of lung cancer

Francesco Givigliano, MD, Antonello La Rocca, MD, Michele Salati, MD, Luigi Busiello, MD, Carmine La Manna, MD, Francesco Scognamiglio, MD, Gaetano Rocco, MD, FRCS (Ed), FECTS*

Division of Thoracic Surgery, National Cancer Institute, Pascale Foundation, Naples, Italy

Received for publication August 22, 2007; accepted for publication October 17, 2007.

* Address for reprints: Gaetano Rocco, MD, FRCS (Ed), FECTS, Division of Thoracic Surgery, National Cancer Institute, Pascale Foundation, Via M. Semmola, 81, 80131, Naples, Italy. (Email: Gaetano.Rocco@btopenworld.com).

The first 20% of the full text of this article appears below.

The incidence of pneumothorax resulting from bronchoalveolar fistula complicating primary or secondary lung cancer ranges between 1% and 4%.1Go Because of the rarity of this condition (4 cases out of 663 admissions for lung cancer [0.4%] during a 2-year period in our institution), preventing the accumulation of large numbered series, and the anecdotal nature of the reported cases, it has not been possible to investigate the pathophysiology and codify the possible therapeutic pathways indicated in the management of this particular type of . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The American Association for Thoracic Surgery.